Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 4 July 2003: Vol. 301. no. 5629, pp. 94 - 96 DOI: 10.1126/science.1082015
|
|
Reports
Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli
Alireza Alavi,*
John D. Hood,*
Ricardo Frausto,
Dwayne G. Stupack,
David A. Cheresh
Raf kinases have been linked to endothelial cell survival. Here, we show that basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) differentially activate Raf, resulting in protection from distinct pathways of apoptosis in human endothelial cells and chick embryo vasculature. bFGF activated Raf-1 via p21-activated protein kinase1 (PAK-1) phosphorylation of serines 338 and 339, resulting in Raf-1 mitochondrial translocation and endothelial cell protection from the intrinsic pathway of apoptosis, independent of the mitogen-activated protein kinase kinase1 (MEK1). In contrast, VEGF activated Raf-1 via Src kinase, leading to phosphorylation of tyrosines 340 and 341 and MEK1-dependent protection from extrinsic-mediated apoptosis. These findings implicate Raf-1 as a pivotal regulator of endothelial cell survival during angiogenesis.
Department of Immunology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: cheresh{at}scripps.edu
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer.
- S. Yang, V. C. Ngo, G. B. Lew, L. W. V. Chong, S. S. Lee, W. J. R. Ong, W. L. I. Lam, C. H. Thng, H. N. Koong, H. S. Ong, et al. (2009)
Mol. Cancer Ther.
8, 2537-2545
| Abstract »
| Full Text »
| PDF »
- Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.
- G. Wei, R. Srinivasan, C. Z. Cantemir-Stone, S. M. Sharma, R. Santhanam, M. Weinstein, N. Muthusamy, A. K. Man, R. G. Oshima, G. Leone, et al. (2009)
Blood
114, 1123-1130
| Abstract »
| Full Text »
| PDF »
- Formation of endothelial lumens requires a coordinated PKC{epsilon}-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation.
- W. Koh, K. Sachidanandam, A. N. Stratman, A. Sacharidou, A. M. Mayo, E. A. Murphy, D. A. Cheresh, and G. E. Davis (2009)
J. Cell Sci.
122, 1812-1822
| Abstract »
| Full Text »
| PDF »
- Regulation of RAF Activity by 14-3-3 Proteins: RAF KINASES ASSOCIATE FUNCTIONALLY WITH BOTH HOMO- AND HETERODIMERIC FORMS OF 14-3-3 PROTEINS.
- A. Fischer, A. Baljuls, J. Reinders, E. Nekhoroshkova, C. Sibilski, R. Metz, S. Albert, K. Rajalingam, M. Hekman, and U. R. Rapp (2009)
J. Biol. Chem.
284, 3183-3194
| Abstract »
| Full Text »
| PDF »
- Sorafenib in Advanced Hepatocellular Carcinoma.
- G. Spinzi, S. Paggi, M. S. Copur, D. H. Palmer, J. M. Llovet, J. Bruix, and L. R. Roberts (2008)
N. Engl. J. Med.
359, 2497-2499
| Full Text »
| PDF »
- Disruption of the Transcription Factor Nrf2 Promotes Pro-Oxidative Dendritic Cells That Stimulate Th2-Like Immunoresponsiveness upon Activation by Ambient Particulate Matter.
- M. A. Williams, T. Rangasamy, S. M. Bauer, S. Killedar, M. Karp, T. W. Kensler, M. Yamamoto, P. Breysse, S. Biswal, and S. N. Georas (2008)
J. Immunol.
181, 4545-4559
| Abstract »
| Full Text »
| PDF »
- Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors.
- L. Dal Lago, V. D'Hondt, and A. Awada (2008)
Oncologist
13, 845-858
| Abstract »
| Full Text »
| PDF »
- Isoform-specific Interaction of C-RAF with Mitochondria.
- A. Galmiche, J. Fueller, A. Santel, G. Krohne, I. Wittig, A. Doye, M. Rolando, G. Flatau, E. Lemichez, and U. R. Rapp (2008)
J. Biol. Chem.
283, 14857-14866
| Abstract »
| Full Text »
| PDF »
- A Small Molecule Disruptor of Rb/Raf-1 Interaction Inhibits Cell Proliferation, Angiogenesis, and Growth of Human Tumor Xenografts in Nude Mice.
- R. Kinkade, P. Dasgupta, A. Carie, D. Pernazza, M. Carless, S. Pillai, N. Lawrence, S. M. Sebti, and S. Chellappan (2008)
Cancer Res.
68, 3810-3818
| Abstract »
| Full Text »
| PDF »
- Distinct Angiogenic Mediators Are Required for Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor-induced Angiogenesis: The Role of Cytoplasmic Tyrosine Kinase c-Abl in Tumor Angiogenesis.
- W. Yan, B. Bentley, and R. Shao (2008)
Mol. Biol. Cell
19, 2278-2288
| Abstract »
| Full Text »
| PDF »
- Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation.
- P.-Y. Chang, S.-C. Lu, C.-M. Lee, Y.-J. Chen, T. A. Dugan, W.-H. Huang, S.-F. Chang, W. S.L. Liao, C.-H. Chen, and Y.-T. Lee (2008)
Circ. Res.
102, 933-941
| Abstract »
| Full Text »
| PDF »
- KLF2 Transcription Factor Modulates Blood Vessel Maturation through Smooth Muscle Cell Migration.
- J. Wu, C. S. Bohanan, J. C. Neumann, and J. B. Lingrel (2008)
J. Biol. Chem.
283, 3942-3950
| Abstract »
| Full Text »
| PDF »
- Combining Agents that Target the Tumor Microenvironment Improves the Efficacy of Anticancer Therapy.
- J. A. Blansfield, D. Caragacianu, H. R. Alexander III, M. A. Tangrea, S. Y. Morita, D. Lorang, P. Schafer, G. Muller, D. Stirling, R. E. Royal, et al. (2008)
Clin. Cancer Res.
14, 270-280
| Abstract »
| Full Text »
| PDF »
- Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers.
- C. Widakowich, G. de Castro Jr., E. de Azambuja, P. Dinh, and A. Awada (2007)
Oncologist
12, 1443-1455
| Abstract »
| Full Text »
| PDF »
- NADPH Oxidase Activity Selectively Modulates Vascular Endothelial Growth Factor Signaling Pathways.
- Md. R. Abid, K. C. Spokes, S.-C. Shih, and W. C. Aird (2007)
J. Biol. Chem.
282, 35373-35385
| Abstract »
| Full Text »
| PDF »
- JAK2 Tyrosine Kinase Phosphorylates PAK1 and Regulates PAK1 Activity and Functions.
- L. Rider, A. Shatrova, E. P. Feener, L. Webb, and M. Diakonova (2007)
J. Biol. Chem.
282, 30985-30996
| Abstract »
| Full Text »
| PDF »
- Src Family Kinases Promote Vessel Stability by Antagonizing the Rho/ROCK Pathway.
- E. Im and A. Kazlauskas (2007)
J. Biol. Chem.
282, 29122-29129
| Abstract »
| Full Text »
| PDF »
- Grb10 and Active Raf-1 Kinase Promote Bad-dependent Cell Survival.
- S. Kebache, J. Ash, M. G. Annis, J. Hagan, M. Huber, J. Hassard, C. L. Stewart, M. Whiteway, and A. Nantel (2007)
J. Biol. Chem.
282, 21873-21883
| Abstract »
| Full Text »
| PDF »
- Chemoresistance of Endothelial Cells Induced by Basic Fibroblast Growth Factor Depends on Raf-1-Mediated Inhibition of the Proapoptotic Kinase, ASK1.
- A. S. Alavi, L. Acevedo, W. Min, and D. A. Cheresh (2007)
Cancer Res.
67, 2766-2772
| Abstract »
| Full Text »
| PDF »
- The power and promise of "rewiring" the mitogen-activated protein kinase network in prostate cancer therapeutics.
- A. G. Papatsoris, M. V. Karamouzis, and A. G. Papavassiliou (2007)
Mol. Cancer Ther.
6, 811-819
| Abstract »
| Full Text »
| PDF »
- Controlled Release of Basic Fibroblast Growth Factor From Gelatin Hydrogel Sheet Improves Structural and Physiological Properties of Vein Graft in Rat.
- T. Haraguchi, K. Okada, Y. Tabata, Y. Maniwa, Y. Hayashi, and Y. Okita (2007)
Arterioscler Thromb Vasc Biol
27, 548-555
| Abstract »
| Full Text »
| PDF »
- Sorafenib and Sunitinib in the Treatment of Advanced Non-Small Cell Lung Cancer.
- C. Gridelli, P. Maione, F. Del Gaizo, G. Colantuoni, C. Guerriero, C. Ferrara, D. Nicolella, D. Comunale, A. De Vita, and A. Rossi (2007)
Oncologist
12, 191-200
| Abstract »
| Full Text »
| PDF »
- Cortical Migration Defects in Mice Expressing A-RAF from the B-RAF Locus..
- G. Camarero, O. Y. Tyrsin, C. Xiang, V. Pfeiffer, S. Pleiser, S. Wiese, R. Gotz, and U. R. Rapp (2006)
Mol. Cell. Biol.
26, 7103-7115
| Abstract »
| Full Text »
| PDF »
- Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature.
- A. Dhanasekaran, R. Al-Saghir, B. Lopez, D. Zhu, D. D. Gutterman, E. R. Jacobs, and M. Medhora (2006)
Am J Physiol Heart Circ Physiol
291, H517-H531
| Abstract »
| Full Text »
| PDF »
- Focal Adhesion Kinase Controls Cellular Levels of p27/Kip1 and p21/Cip1 through Skp2-Dependent and -Independent Mechanisms..
- P. Bryant, Q. Zheng, and K. Pumiglia (2006)
Mol. Cell. Biol.
26, 4201-4213
| Abstract »
| Full Text »
| PDF »
- Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors.
- H. Richly, B. F. Henning, P. Kupsch, K. Passarge, M. Grubert, R. A. Hilger, O. Christensen, E. Brendel, B. Schwartz, M. Ludwig, et al. (2006)
Ann. Onc.
17, 866-873
| Abstract »
| Full Text »
| PDF »
- Mechanisms of Hypertension Associated With BAY 43-9006.
- M. L. Veronese, A. Mosenkis, K. T. Flaherty, M. Gallagher, J. P. Stevenson, R. R. Townsend, and P. J. O'Dwyer (2006)
J. Clin. Oncol.
24, 1363-1369
| Abstract »
| Full Text »
| PDF »
- Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation.
- R. Braren, H. Hu, Y. H. Kim, H. E. Beggs, L. F. Reichardt, and R. Wang (2006)
J. Cell Biol.
172, 151-162
| Abstract »
| Full Text »
| PDF »
- Role of Group A p21-activated Kinases in Activation of Extracellular-regulated Kinase by Growth Factors.
- A. Beeser, Z. M. Jaffer, C. Hofmann, and J. Chernoff (2005)
J. Biol. Chem.
280, 36609-36615
| Abstract »
| Full Text »
| PDF »
- Raf: A Strategic Target for Therapeutic Development Against Cancer.
- M. Beeram, A. Patnaik, and E. K. Rowinsky (2005)
J. Clin. Oncol.
23, 6771-6790
| Abstract »
| Full Text »
| PDF »
- Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis.
- M.-T. Huang, J. C. Mason, G. M. Birdsey, V. Amsellem, N. Gerwin, D. O. Haskard, A. J. Ridley, and A. M. Randi (2005)
Blood
106, 1636-1643
| Abstract »
| Full Text »
| PDF »
- p21-activated Kinase 1 (Pak1)-dependent Phosphorylation of Raf-1 Regulates Its Mitochondrial Localization, Phosphorylation of BAD, and Bcl-2 Association.
- S. Jin, Y. Zhuo, W. Guo, and J. Field (2005)
J. Biol. Chem.
280, 24698-24705
| Abstract »
| Full Text »
| PDF »
- CNK1 Is a Scaffold Protein That Regulates Src-mediated Raf-1 Activation.
- A. Ziogas, K. Moelling, and G. Radziwill (2005)
J. Biol. Chem.
280, 24205-24211
| Abstract »
| Full Text »
| PDF »
- Fibroblast Growth Factor-10 Prevents Asbestos-Induced Alveolar Epithelial Cell Apoptosis by a Mitogen-Activated Protein Kinase-Dependent Mechanism.
- D. Upadhyay, V. Panduri, and D. W. Kamp (2005)
Am. J. Respir. Cell Mol. Biol.
32, 232-238
| Abstract »
| Full Text »
| PDF »
- Disruption of the Shc/Grb2 Complex during Abelson Virus Transformation Affects Proliferation, but Not Apoptosis.
- L. B. Baughn and N. Rosenberg (2005)
J. Virol.
79, 2325-2334
| Abstract »
| Full Text »
| PDF »
- Vascular endothelial growth factor and related molecules in acute lung injury.
- M. Mura, C. C. dos Santos, D. Stewart, and M. Liu (2004)
J Appl Physiol
97, 1605-1617
| Abstract »
| Full Text »
| PDF »
- Disruption of the Rb-Raf-1 Interaction Inhibits Tumor Growth and Angiogenesis.
- P. Dasgupta, J. Sun, S. Wang, G. Fusaro, V. Betts, J. Padmanabhan, S. M. Sebti, and S. P. Chellappan (2004)
Mol. Cell. Biol.
24, 9527-9541
| Abstract »
| Full Text »
| PDF »
- Vascular Endothelial Growth Factor-mediated Induction of Manganese Superoxide Dismutase Occurs through Redox-dependent Regulation of Forkhead and I{kappa}B/NF-{kappa}B.
- Md. R. Abid, I. G. Schoots, K. C. Spokes, S.-Q. Wu, C. Mawhinney, and W. C. Aird (2004)
J. Biol. Chem.
279, 44030-44038
| Abstract »
| Full Text »
| PDF »
- BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis.
- S. M. Wilhelm, C. Carter, L. Tang, D. Wilkie, A. McNabola, H. Rong, C. Chen, X. Zhang, P. Vincent, M. McHugh, et al. (2004)
Cancer Res.
64, 7099-7109
| Abstract »
| Full Text »
| PDF »
- Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas.
- E. J. Douglas, H. Fiegler, A. Rowan, S. Halford, D. C. Bicknell, W. Bodmer, I. P. M. Tomlinson, and N. P. Carter (2004)
Cancer Res.
64, 4817-4825
| Abstract »
| Full Text »
| PDF »
- Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs.
- Y. Takenaka, T. Fukumori, T. Yoshii, N. Oka, H. Inohara, H.-R. C. Kim, R. S. Bresalier, and A. Raz (2004)
Mol. Cell. Biol.
24, 4395-4406
| Abstract »
| Full Text »
| PDF »
- Dynamic Changes in C-Raf Phosphorylation and 14-3-3 Protein Binding in Response to Growth Factor Stimulation: DIFFERENTIAL ROLES OF 14-3-3 PROTEIN BINDING SITES.
- M. Hekman, S. Wiese, R. Metz, S. Albert, J. Troppmair, J. Nickel, M. Sendtner, and U. R. Rapp (2004)
J. Biol. Chem.
279, 14074-14086
| Abstract »
| Full Text »
| PDF »
- Adenovirus E4 Gene Promotes Selective Endothelial Cell Survival and Angiogenesis via Activation of the Vascular Endothelial-Cadherin/Akt Signaling Pathway.
- F. Zhang, J. Cheng, N. R. Hackett, G. Lam, K. Shido, R. Pergolizzi, D. K. Jin, R. G. Crystal, and S. Rafii (2004)
J. Biol. Chem.
279, 11760-11766
| Abstract »
| Full Text »
| PDF »
- P21Waf1/Cip1 in endothelial cell survival.
- F. Aoudjit and J. Sevigny (2004)
Cardiovasc Res
61, 648-650
| Full Text »
| PDF »
- SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Causes Accumulation of Phosphorylated ERK Kinases and Inhibits Their Activity in Vivo and in Vitro.
- G. Boguslawski, P. W. McGlynn, K. A. Harvey, and A. T. Kovala (2004)
J. Biol. Chem.
279, 5716-5724
| Abstract »
| Full Text »
| PDF »
- Etk/Bmx Transactivates Vascular Endothelial Growth Factor 2 and Recruits Phosphatidylinositol 3-Kinase to Mediate the Tumor Necrosis Factor-induced Angiogenic Pathway.
- R. Zhang, Y. Xu, N. Ekman, Z. Wu, J. Wu, K. Alitalo, and W. Min (2003)
J. Biol. Chem.
278, 51267-51276
| Abstract »
| Full Text »
| PDF »
- Differential {alpha}v integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.
- J. D. Hood, R. Frausto, W. B. Kiosses, M. A. Schwartz, and D. A. Cheresh (2003)
J. Cell Biol.
162, 933-943
| Abstract »
| Full Text »
| PDF »
|
|